Oct 28, 2022
In this episode, guest host Deepak Bhatt, MD, MPH, FACC, offers a preview of some of the most important and clinically transformative studies being presented at the AHA 2022 Conference, November 5-7.
Day One includes two major studies on diuretics: primary results from the TRANSFORM HF Trial, examining the...
Oct 26, 2022
In this week’s View, Dr. Eagle discusses the European Atherosclerosis Society’s consensus statement on lipoprotein(a) [Lp(a)] in atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, then looks at CHD screening in kidney and liver transplant candidates.
Oct 19, 2022
In this week’s View, Dr. Eagle discusses the TIME Study, a prospective, randomized, open-labe,l blinded-endpoint clinical trial exploring cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives, then looks at phenotyping the hypertensive heart. Finally, Dr....
Oct 12, 2022
In this week’s View, Dr. Deepak Bhatt sits in for Dr. Eagle to discuss TIMING, a registry-based randomized controlled noninferiority study that examines early versus delayed non–Vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation, then looks at the Fingersture study...
Oct 5, 2022
In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment...